Coronavirus

The race for the presidency may still be too close to call. But Wall Street has already declared a winner: technology stocks. The Nasdaq rose nearly 4% yesterday, easily… Read more

The presidential 2020 election result is still up in the air. So, let me give you some good news on the virus. Our body’s immune response to viral infection… Read more

Today is Election Day, so if you haven’t voted yet, please do. As an investor,  you may have a big question on your mind about the election outcome: Are… Read more

Regeneron (NASDAQ: REGN) has stopped enrolling seriously ill Covid-19 patients in a clinical trial of its antibody treatment. This is the antibody “cocktail” President Trump received during his treatment… Read more

Yesterday was “Super Thursday” for technology stocks as many of the world’s largest companies reported results. As our economy shows tentative signs of improvement, Amazon, Apple, Alphabet and Facebook… Read more

Coronavirus has likely become the leading cause of death among young people in some regions of the U.S., says a new study. It’s another big hole blown into the… Read more

There is another promising line of attack against the coronavirus. . .T-cells. This new line of attack was revealed in a new study published in Blood. T-cells taken from… Read more

Natural immunity (high antibody levels) may not last more than a few months, a study from England suggests. It’s just the latest study to report such findings. That means… Read more

It looks like the Trump administration is waving the white flag. It is surrendering to the virus. Over the weekend, President Trump’s chief of staff, Mark Meadows, said, “We… Read more